🚀 VC round data is live in beta, check it out!
Solesence Valuation Multiples
Discover revenue and EBITDA valuation multiples for Solesence and similar public comparables like MPM Corporeos, Suominen, Dr. Miele Cosmed Group, Hain Celestial Group and more.
Solesence Overview
About Solesence
Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.
Founded
1989
HQ
Employees
98
Website
Sectors
Financials (FY)
EV
$108M
Solesence Financials
Solesence reported last fiscal year revenue of $52M and EBITDA of $6M.
In the same fiscal year, Solesence generated $16M in gross profit, $6M in EBITDA, and $4M in net income.
Solesence P&L
In the most recent fiscal year, Solesence reported revenue of $52M and EBITDA of $6M.
Solesence expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $52M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $16M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 31% | XXX | XXX | XXX |
| EBITDA | — | XXX | $6M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Profit | — | XXX | $4M | XXX | XXX | XXX |
| Net Margin | — | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Solesence Stock Performance
Solesence has current market cap of $83M, and enterprise value of $108M.
Market Cap Evolution
Solesence's stock price is $1.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $108M | $83M | 0.0% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSolesence Valuation Multiples
Solesence trades at 2.1x EV/Revenue multiple, and 17.8x EV/EBITDA.
Solesence Financial Valuation Multiples
As of March 15, 2026, Solesence has market cap of $83M and EV of $108M.
Equity research analysts estimate Solesence's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Solesence has a P/E ratio of 19.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $83M | XXX | $83M | XXX | XXX | XXX |
| EV (current) | $108M | XXX | $108M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 17.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 21.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.7x | XXX | XXX | XXX |
| P/E | — | XXX | 19.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (41.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Solesence Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Solesence Margins & Growth Rates
Solesence's revenue in the last fiscal year grew by 40%.
Solesence Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 40% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (316%) | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Solesence Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MPM Corporeos | XXX | XXX | XXX | XXX | XXX | XXX |
| Suominen | XXX | XXX | XXX | XXX | XXX | XXX |
| Dr. Miele Cosmed Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Hain Celestial Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Culti Milano | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Solesence M&A Activity
Solesence acquired XXX companies to date.
Last acquisition by Solesence was on XXXXXXXX, XXXXX. Solesence acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Solesence
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSolesence Investment Activity
Solesence invested in XXX companies to date.
Solesence made its latest investment on XXXXXXXX, XXXXX. Solesence invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Solesence
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Solesence
| When was Solesence founded? | Solesence was founded in 1989. |
| Where is Solesence headquartered? | Solesence is headquartered in United States. |
| How many employees does Solesence have? | As of today, Solesence has over 98 employees. |
| Who is the CEO of Solesence? | Solesence's CEO is Kevin Cureton. |
| Is Solesence publicly listed? | Yes, Solesence is a public company listed on Nasdaq. |
| What is the stock symbol of Solesence? | Solesence trades under SLSN ticker. |
| When did Solesence go public? | Solesence went public in 1997. |
| Who are competitors of Solesence? | Solesence main competitors are MPM Corporeos, Suominen, Dr. Miele Cosmed Group, Hain Celestial Group. |
| What is the current market cap of Solesence? | Solesence's current market cap is $83M. |
| What is the current revenue of Solesence? | Solesence's last fiscal year revenue is $52M. |
| What is the current EV/Revenue multiple of Solesence? | Current revenue multiple of Solesence is 2.1x. |
| Is Solesence profitable? | No, Solesence is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.